Acasti Pharma Inc. (NASDAQ:ACST)
Industry: Healthcare

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Current Quote*
Last: $0.907
Change: 0.027
Book: $Unk
Volume: 396,388

As Of: 04/24 13:14 ET
*Quotes delayed by 20min.

Graphs for ACST

3 Month Graph

6 Month Graph

1 Year Graph